IBRN iShares Neuroscience and Healthcare ETF
Issuer
IShares
Inception
Aug 24, 2022
AUM
$8.6M
Expense ratio
0.47%
Yield
0.92%
Asset class
Equity
Holdings
67
Last price
$34.58
The iShares Neuroscience and Healthcare ETF (IBRN) aims to mirror the financial performance of a particular index. This index consists of companies, both domestically in the U.S. and from other countries, that are expected to benefit from new discoveries and the overall growth in the field of neuroscience.
+19.0%
2025-11-13low 28.85 · high 40.672026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| IBRN | +14.1% | -11.6% | +7.0% | +19.8% | +20.2% | +7.1% |
| Equity average (4615 funds) | -2.1% | +2.7% | +87.8% | +61326.5% | +13.9% | +2.4% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$726K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| RAPP RAPPORT THERAPEUTICS | 1.12% | $22.0M | $4.5M |
| SRRK SCHOLAR ROCK HOLDING | 3.82% | $12.0M | $0 |
| PRTA PROTHENA PLC | 0.41% | $9.8M | $0 |
| XENE XENON PHARMACEUTICALS | 3.20% | $1.7M | $426K |
| MOBI MOBIA MEDICAL INC | 0.28% | $423K | $0 |
| LRMR LARIMAR THERAPEUTICS | 0.11% | $382K | $0 |
| ANNX ANNEXON | 1.00% | $100K | $0 |
| TNXP TONIX PHARMACEUTICALS HOLDING | 0.05% | $60K | $0 |
| DYN DYNE THERAPEUTICS | 3.36% | $40K | $248K |
| CAMP CAMP4 THERAPEUTICS CORP | 0.23% | $40K | $2.5M |
| VNDA VANDA PHARMACEUTICALS INC | 0.37% | $38K | $0 |
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | BIIB BIOGEN | 5.23% |
| 2 | NBIX NEUROCRINE BIOSCIENCES | 5.08% |
| 3 | EWTX EDGEWISE THERAPEUTICS | 5.00% |
| 4 | ALKS ALKERMES | 4.70% |
| 5 | PRAX PRAXIS PRECISION MEDICINES | 4.45% |
| 6 | AXGN AXOGEN | 4.39% |
| 7 | ARGX ARGENX SE ADR | 4.28% |
| 8 | PTCT PTC THERAPEUTICS | 4.26% |
| 9 | SRRK SCHOLAR ROCK HOLDING | 3.82% |
| 10 | DNTH DIANTHUS THERAPEUTICS | 3.73% |
| 11 | 326030.KS SK BIOPHARMACEUTICALS LTD | 3.64% |
| 12 | HLUN-B.CO H. LUNDBECK CLASS B | 3.51% |
| 13 | DYN DYNE THERAPEUTICS | 3.36% |
| 14 | XENE XENON PHARMACEUTICALS | 3.20% |
| 15 | ACAD ACADIA PHARMACEUTICALS | 2.98% |
| 16 | BHVN BIOHAVEN | 2.80% |
| 17 | NEU.AX NEUREN PHARMACEUTICALS | 2.58% |
| 18 | SRPT SAREPTA THERAPEUTICS | 2.42% |
| 19 | BIOA-B.ST BIOARCTIC CLASS B | 1.92% |
| 20 | 4588.T ONCOLYS BIOPHARMA INC | 1.84% |
| 21 | LBRX LB PHARMACEUTICALS INC | 1.69% |
| 22 | TSHA TAYSHA GENE THERAPIES | 1.63% |
| 23 | ANRO ALTO NEUROSCIENCE | 1.58% |
| 24 | RUBICON.NS RUBICON RESEARCH | 1.34% |
| 25 | IDIA.SW IDORSIA N LTD | 1.29% |
| 26 | MEDCL.PA MEDINCELL SA | 1.13% |
| 27 | RAPP RAPPORT THERAPEUTICS | 1.12% |
| 28 | DYVOX.ST DYNAVOX GROUP | 1.08% |
| 29 | IART INTEGRA LIFESCIENCES HOLDINGS | 1.05% |
| 30 | CBLL CERIBELL | 1.02% |
| 31 | ANNX ANNEXON | 1.00% |
| 32 | SLDB SOLID BIOSCIENCES INC | 0.96% |
| 33 | APMD APNIMED INC | 0.95% |
| 34 | CAPR CAPRICOR THERAPEUTICS | 0.84% |
| 35 | OVID OVID THERAPEUTICS | 0.72% |
| 36 | BWAY BRAINSWAY ADR REPRESENTING LTD | 0.60% |
| 37 | NGNE NEUROGENE | 0.59% |
| 38 | DSGN DESIGN THERAPEUTICS | 0.54% |
| 39 | PEPG PEPGEN | 0.52% |
| 40 | 7666.HK METIS TECHBIO CLASS H | 0.52% |
| 41 | NPCE NEUROPACE | 0.52% |
| 42 | 2190.HK ZYLOX-TONBRIDGE MEDICAL TECH H | 0.51% |
| 43 | BNTC BENITEC BIOPHARMA INC | 0.51% |
| 44 | 4592.T SANBIO LTD | 0.46% |
| 45 | PRTA PROTHENA PLC | 0.41% |
| 46 | CLPT CLEARPOINT NEURO INC | 0.39% |
| 47 | SANN.SW SANTHERA N AG | 0.39% |
| 48 | VNDA VANDA PHARMACEUTICALS INC | 0.37% |
| 49 | KYTX KYVERNA THERAPEUTICS | 0.31% |
| 50 | NWRN.SW NEWRON PHARMACEUTICALS | 0.30% |
| 51 | MOBI MOBIA MEDICAL INC | 0.28% |
| 52 | 2172.HK MICROPORT NEUROTECH CORP | 0.27% |
| 53 | DRUG BRIGHT MINDS BIOSCIENCES | 0.27% |
| 54 | CAMP CAMP4 THERAPEUTICS CORP | 0.23% |
| 55 | ABEO ABEONA THERAPEUTICS INC | 0.19% |
| 56 | ALEC ALECTOR | 0.18% |
| 57 | NGEN NERVGEN PHARMA CORP | 0.18% |
| 58 | NERV MINERVA NEUROSCIENCES INC | 0.16% |
| 59 | CGTX COGNITION THERAPEUTICS INC | 0.11% |
| 60 | LRMR LARIMAR THERAPEUTICS | 0.11% |
| 61 | TRDA ENTRADA THERAPEUTICS | 0.10% |
| 62 | IBRN USD CASH | 0.07% |
| 63 | VYGR VOYAGER THERAPEUTICS | 0.07% |
| 64 | AVXL ANAVEX LIFE SCIENCES CORP | 0.06% |
| 65 | MPLT MAPLIGHT THERAPEUTICS | 0.06% |
| 66 | ABOS ACUMEN PHARMACEUTICALS INC | 0.05% |
| 67 | TNXP TONIX PHARMACEUTICALS HOLDING | 0.05% |
| 68 | SUPN SUPERNUS | 0.00% |
Sector breakdown
Health Care98.2%
Information Technology1.1%
Cash and/or Derivatives0.7%
Country breakdown
United States72.9%
Belgium4.2%
South Korea4.1%
Denmark3.4%
Sweden3.2%
Australia2.7%
Japan2.4%
Switzerland2.2%
China1.5%
India1.4%
France1.2%
Other0.8%
Distributions
| Date | Per unit |
|---|---|
| Dec 16, 2025 | $0.3198 |
| Dec 17, 2024 | $0.1011 |
| Dec 20, 2023 | $0.0063 |
| Jun 7, 2023 | $0.0082 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in IBRN in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error